Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. (Record no. 21450165)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02206 a2200673 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516072849.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201207s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1365-2133 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1111/j.1365-2133.2012.10818.x |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Goteri, G |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120709 |
245 00 - TITLE STATEMENT | |
Title | Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The British journal of dermatology |
Date of publication, distribution, etc. | May 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 948-52 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemokine CCL27 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Combined Modality Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon alpha-2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon-alpha |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mycosis Fungoides |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | PUVA Therapy |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rupoli, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Campanati, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zizzi, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Picardi, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cardelli, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Giantomassi, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Canafoglia, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marchegiani, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mozzicafreddo, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brandozzi, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stramazzotti, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ganzetti, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lisa, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Simonetti, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Offidani, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Federici, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Filosa, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leoni, P |
773 0# - HOST ITEM ENTRY | |
Title | The British journal of dermatology |
Related parts | vol. 166 |
-- | no. 5 |
-- | p. 948-52 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1365-2133.2012.10818.x">https://doi.org/10.1111/j.1365-2133.2012.10818.x</a> |
Public note | Available from publisher's website |
No items available.